Home Cart Sign in  
Chemical Structure| 87205-99-0 Chemical Structure| 87205-99-0

Structure of Dihydrotanshinone I
CAS No.: 87205-99-0

Chemical Structure| 87205-99-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dihydrotanshinone I, a natural product isolated and purified from the roots of Salvia miltiorrhiza Bge., exhibits dose-dependent inhibition towards HLM-catalyzed propofol glucuronidation. Dihydrotanshinone I showed inhibitory effect on PL(pro) with IC50 value of 4.9μM and less inhibitory effect on 3CLpro with IC50 value of 14.4μM.

Synonyms: 15,16-Dihydrotanshinone I; DHTS

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dihydrotanshinone I

CAS No. :87205-99-0
Formula : C18H14O3
M.W : 278.30
SMILES Code : O=C(C1=C2C=CC3=C1C=CC=C3C)C(C4=C2OC[C@@H]4C)=O
Synonyms :
15,16-Dihydrotanshinone I; DHTS
MDL No. :MFCD28016070
InChI Key :HARGZZNYNSYSGJ-JTQLQIEISA-N
Pubchem ID :11425923

Safety of Dihydrotanshinone I

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H332-H372-H400
Precautionary Statements:P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
4T1 cells IC50: 6.97 μM 24 hours Inhibited cell proliferation, IC50 of 6.97 μM Int J Mol Sci. 2022 Dec 2;23(23):15180
8505C-PTX cells 2.5 µM 72 hours Evaluate the effect of DHT on the viability of PTX-resistant cells, results showed DHT significantly reduced cell viability Int J Mol Sci. 2021 Jul 28;22(15):8083
SW1736-PTX cells 2.5 µM 72 hours Evaluate the effect of DHT on the viability of PTX-resistant cells, results showed DHT significantly reduced cell viability Int J Mol Sci. 2021 Jul 28;22(15):8083
PMNs cells 0.5–128 μM 8 hours Increased cell viability Int J Mol Sci. 2022 Dec 2;23(23):15180
SKBR-3 cells IC50: 17.87 μM 24 hours Inhibited cell proliferation, IC50 of 17.87 μM Int J Mol Sci. 2022 Dec 2;23(23):15180
MCF-7 cells IC50: 34.11 μM 24 hours Inhibited cell proliferation, IC50 of 34.11 μM Int J Mol Sci. 2022 Dec 2;23(23):15180
MDA-MB-231 cells IC50: 117.71 μM 24 hours Inhibited cell proliferation, IC50 of 117.71 μM Int J Mol Sci. 2022 Dec 2;23(23):15180
HCT116 cells 10 µM 15 days To assess the inhibitory effect of DHTS on tumor spheroid growth Nucleic Acids Res. 2017 Sep 19;45(16):9514-9527
HeLa cells 10 µM To evaluate the interference of DHTS with HuR binding to target mRNAs Nucleic Acids Res. 2017 Sep 19;45(16):9514-9527
NIH-3T3 fibroblasts 37.5, 75, 150 nM 12 hours Blocking the downstream of CD44-RhoA-YAP signaling pathway, reducing YAP nuclear translocation, and inhibiting fibroblast migration, invasion, proliferation, and collagen deposition. Theranostics. 2019 Jul 9;9(17):4993-5008
RAW264.7 macrophages 10, 50, 100 nM 24 hours To evaluate the inhibitory effect of DHT on LPS-induced inflammatory response in macrophages, results showed DHT reduced the release of TNF-α and IL-1β and inhibited the activation of M1 macrophages J Exp Clin Cancer Res. 2020 May 24;39(1):93
H9C2 cardiomyocytes 10 nM 24 hours To evaluate the inhibitory effect of DHT on DOX-induced inflammatory response in cardiomyocytes, results showed DHT downregulated the expressions of p-NF-κB, TNF-α, and COX2 J Exp Clin Cancer Res. 2020 May 24;39(1):93
Rat primary hepatic stellate cells (pHSCs) 1, 5, 10 μmol/L DHI dose-dependently inhibited the mRNA expression of various fibrogenic genes, including TGFβ1, α-SMA and COL1A1, in rat pHSCs. Br J Pharmacol. 2017 May;174(10):1147-1160
LX-2 cells 1, 5, 10 μmol/L DHI dose-dependently inhibited the mRNA expression of various fibrogenic genes, including TGFβ1, α-SMA and COL1A1, in LX-2 cells. Br J Pharmacol. 2017 May;174(10):1147-1160
HL-60 cells 0.5~2.5 μg/mL 24 hours DHTS significantly inhibited HL-60 cell proliferation, induced apoptosis, activated caspase-3, -8, and -9, leading to PARP cleavage. Int J Mol Sci. 2015 Aug 17;16(8):19387-400

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice 4T1 spontaneous metastasis model Intraperitoneal injection 10 mg/kg or 20 mg/kg Once daily for 25 days Inhibited tumor growth and lung metastasis, lung fluorescence intensity decreased by 74.9% in DHT-H group Int J Mol Sci. 2022 Dec 2;23(23):15180
Nude mice HCT116 xenograft model Intraperitoneal injection 10 mg/kg Every 48 hours for 31 days To evaluate the inhibitory effect of DHTS on tumor growth Nucleic Acids Res. 2017 Sep 19;45(16):9514-9527
C57BL/6 mice Crystalline silica-induced silicosis model Intragastric administration 150, 75, 37.5 mg/kg Once daily for 7 days By blocking the CD44-RhoA-YAP signaling pathway, it alleviates crystalline silica-induced pulmonary fibrosis and improves pulmonary function. Theranostics. 2019 Jul 9;9(17):4993-5008
C57BL/6 mice Doxorubicin-induced cardiotoxicity model Oral 20 mg/kg Once daily for 4 weeks To evaluate the protective effect of DHT on doxorubicin-induced cardiotoxicity, results showed DHT improved cardiac function, reduced inflammatory cell infiltration, and inhibited the activation of M1 macrophages and NF-κB signaling pathway J Exp Clin Cancer Res. 2020 May 24;39(1):93
Sprague-Dawley rats Bile duct ligation (BDL)-induced hepatic fibrosis model Intraperitoneal injection 25 mg/kg/day Once daily for 14 days DHI treatment attenuated liver necrosis, bile duct proliferation and collagen accumulation, and reduced the expression of fibrogenesis-associated genes in BDL rats. Br J Pharmacol. 2017 May;174(10):1147-1160
Nude mice HL-60 xenograft model Intraperitoneal injection 12.5 and 25.0 mg/kg Once daily for one week 25 mg/kg DHTS significantly inhibited HL-60 tumor growth by about 68.0% with no effect on body weight. Int J Mol Sci. 2015 Aug 17;16(8):19387-400

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.59mL

0.72mL

0.36mL

17.97mL

3.59mL

1.80mL

35.93mL

7.19mL

3.59mL

References

 

Historical Records

Categories